Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
BioArctic (Nasdaq Stockholm: BIOA B) issued 5,000 Class B shares in May 2026 through exercise of 5,000 stock options from the 2019/2028 program. As of May 29, 2026, BioArctic has 88,724,485 shares outstanding and 218,324,449 votes in total.
The share capital comprises 74,324,489 listed Class B shares and 14,399,996 unlisted Class A shares. Each A share carries ten votes and each B share one vote.
BioArctic (Nasdaq Stockholm: BIOA B) held its AGM on 28 May 2026 and approved the 2025 income statement and balance sheet, a dividend of SEK 2 per share with record date 1 June 2026, and discharge of the board and CEO.
Shareholders re-elected six directors, elected two new members, and re-elected the chair. The AGM authorised the board to issue new shares, warrants and convertibles of up to 10% of share capital, adopted a three-year PSU incentive program of up to 235,000 units with related hedging, and updated senior executive remuneration guidelines.
Crawford (NYSE:A), a global claims management and outsourcing provider, marks its 85th anniversary by emphasizing future growth and innovation rather than a retrospective.
The company highlights its evolution from a single Georgia office to a worldwide platform using technology, AI-enabled tools, and data-driven insights across the full claims lifecycle.
BioArctic (NASDAQ Stockholm: B) reported that partner Eisai presented a simulation of potential future Leqembi sales at its Investor Relations Day.
According to Eisai, simulated Leqembi sales reach around JPY 300 billion (≈SEK 17.6 billion) in FY2028, ending March 2029. The disclosure was made under EU Market Abuse Regulation rules.
BioArctic (Nasdaq Stockholm: BIOA B) announced that partner Eisai projects Leqembi sales of JPY 143.5 billion (about SEK 8.4 billion) for FY 2026 (April 2026–March 2027), a 63% increase year over year.
This is expected to generate roughly SEK 880 million in royalties to BioArctic. The companies are preparing joint commercialization of Leqembi for Alzheimer's disease in the Nordic region.
The Board of Directors of Crawford & Company (NYSE: CRD-A, CRD-B) approved a quarterly cash dividend of $0.075 per share on both Class A and Class B common stock. The dividend will be paid on June 12, 2026 to shareholders of record on May 29, 2026.
Barrick Mining (NYSE:B) reported voting results from its 2026 annual shareholder meeting. All nine board nominees were elected, with votes for ranging from 81.1% to 99.63%. Shareholders also approved the appointment of the auditor with 93.27% support and passed the advisory resolution on executive compensation with 76.66% support.
Barrick Mining (NYSE:B) is highlighted within a sector-wide reset in gold valuations, as senior producers report realized prices near $4,800–$4,900/oz and record cash flows.
Barrick posted record Q4 2025 operating cash flow of $2.73B, free cash flow of $1.62B, EPS of $1.43, and plans a late‑2026 IPO of a North American gold NewCo. Greenland Mines’ Skaergaard sensitivity study shows higher palladium‑equivalent grades at elevated gold price decks, though these are illustrative and not new reserves or economic estimates.
BioArctic (NASDAQ Stockholm: BIOA B) will publish its first quarter 2026 report for January–March on May 20, 2026 at 8:00 a.m. CET. A webcast and teleconference in English with the CEO and CFO will follow at 9:30 a.m. CET, including a Q&A session.
The webcast requires online registration for written questions, while verbal questions are handled via a separate teleconference registration. A replay will be available on BioArctic's investor website after the presentation.
Octave Intelligence (Ticker: B) will be distributed to Hexagon shareholders, with all Octave shares spun off as Swedish depository receipts (SDRs) or class B ordinary shares.
SDRs are expected to start trading on Nasdaq Stockholm on 25 May 2026 and Octave class B shares on Nasdaq New York via when-issued trading from 21 May 2026 and regular-way trading from 28 May 2026. The record date for the distribution is 22 May 2026, and each SDR represents one class B share.